Drugs, Pregnancy & Lactation
Drugs, Pregnancy & Lactation
2018 FDA-approved new drugs
Drugs, Pregnancy & Lactation
Preventing postpartum depression: Start with women at greatest risk
Women at greatest risk include those with a history of PPD, bipolar disorder, or postpartum psychosis.
Drugs, Pregnancy & Lactation
Antimigraine agents in pregnancy and lactation
Drugs, Pregnancy & Lactation
Pregnancy registries are a valuable resource
Drugs, Pregnancy & Lactation
Options for treatment of bipolar disorder during pregnancy
Drugs, Pregnancy & Lactation
Breastfeeding with the FDA’s novel drugs approved in 2017, and others
Infants should be monitored for the following common adverse effects when breastfeeding mothers are taking any of these drugs.
Drugs, Pregnancy & Lactation
The FDA’s novel drugs approved in 2017
In this month’s Drugs, Pregnancy & Lactation column, Dr. Gerald Briggs explains the state of research on the safety of new drugs for pregnant...
Drugs, Pregnancy & Lactation
Fetal exposure to depression: How does ‘dose’ figure in?
There is a continuum of risk when it comes to the effects of depression during pregnancy.
Drugs, Pregnancy & Lactation
Influenza vaccination of pregnant women needs surveillance
One study found an increased risk of spontaneous abortion associated with vaccination, but this is inconsistent with previous findings.
Drugs, Pregnancy & Lactation
Urinary tract agents: A safety review in pregnancy
There are few data on the use of the 15 approved urinary tract agents in pregnancy and breastfeeding.
Drugs, Pregnancy & Lactation
Postpartum depression: Moving toward improved screening with a new app
The MGH Perinatal Depression Scale (MGHPDS) is an app that screens for postpartum depression during and after pregnancy.